COSMOS HEALTH CEO Issues Letter To Shareholders; Inaugural 2026 Guidance Introduced; Expects To Achieve Over $180M In Gross Annual Revenue And EBITDA In Excess Of $20M
Portfolio Pulse from Benzinga Newsdesk
Cosmos Health Inc. (NASDAQ:COSM) CEO Greg Siokas has issued a letter to shareholders outlining the company's strategic plans and financial outlook. The company has introduced its 2026 guidance, expecting to achieve over $180M in gross annual revenue and EBITDA in excess of $20M. The company has completed three acquisitions in 2023 and is making progress in R&D. The company is also considering spinning off its R&D division into a standalone, publicly listed biotech company. The CEO has invested more than $15M since inception, including almost $1M YTD.
October 05, 2023 | 12:43 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cosmos Health Inc. has introduced its 2026 guidance, expecting to achieve over $180M in gross annual revenue and EBITDA in excess of $20M. The company has completed three acquisitions in 2023 and is making progress in R&D. The company is also considering spinning off its R&D division into a standalone, publicly listed biotech company.
The company's strong financial outlook, successful acquisitions, and progress in R&D are likely to have a positive impact on its stock price. The potential spin-off of the R&D division could also attract investor interest.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100